Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy

Yonsei Medical Journal

Volumn 49, Issue 5, 2008, Pages 811-818

  Kim, Eun Jung ^a   Yoe, Ji Young ^b   Choi, Young Hwan ^a   Ahn, Keun Jae ^a   Lee, Jong Doo ^a   Yun, Chae Ok ^b   Yun, Mijin ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adenovirus; Gene therapy; Oncolysis; Radiotracer; Thymidine kinase

Indexed keywords

ADENOVIRUS VECTOR; FIALURIDINE; GANCICLOVIR; ONCOLYTIC ADENOVIRUS; THYMIDINE KINASE; TRACER;

ANTIVIRAL ACTIVITY; ARTICLE; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFECTION PREVENTION; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; ONCOLYTIC VIROTHERAPY; RADIOACTIVITY; SCINTILLATION CAMERA; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; SIMPLEXVIRUS; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE KINASE; TRANSGENES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 58149462251     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.5.811     Document Type: Article

References (20)

1. Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Transductional and transcriptional targeting of adenovirus for clinical applications. Curr Gene Ther 2004;4:1-14.
2. Barnett BG, Crews CJ, Douglas JT. Targeted adenoviral vectors. Biochim Biophys Acta 2002;1575:1-14.
3. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40.
4. Herminston T. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer. J Clin Invest 2000;105:1169-72.
5. Kirn D. Clinical research results with d11320 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 2001; 8:89-98.
6. Wildner O, Morris JC, Vahanian NN, Ford H Jr, Ramsey WJ, Blaese RM. Adenoviral vectors capable of replication improve the efficacy of HSVtk/ GCV suicide gene therapy of cancer. Gene Ther 1999;6:57-62.
7. Raki M, Hakkarainen T, Bauerschmitz GJ, Särkioja M, Desmond RA, Kanerva A, et al. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus. Gene Ther 2007;14:1380-8.
8. Kim J, Cho JY, Kim JH, Jung KC, Yun CO. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Cancer Gene Ther 2002;9:725-36.
9. Bischoff JR, Kim DH, Williams A, Heise C, Horn S, Muna M, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996;274:373-6.
10. Lee H, Kim J, Lee B, Chang JW, Ahn J, Park JO, et al. Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status. Int J Cancer 2000;88:454-63.
11. Dix BR, O'Carroll SJ, Myers CJ, Edwards SJ, Braithwaite AW. Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53. Cancer Res 2000; 60:2666-72.
12. Braithwaite AW, Russell IA. Induction of cell death by adenoviruses. Apoptosis 2001;6:359-70.
13. Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex cirus-thymidine kinase. Cancer Res 2001;61.8743-50.
14. Haviv YS, Takayama K, Glasgow JN, Blackwell JL, Wang M, Lei X, et al. A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene. Mol Cancer Ther 2002;1:321-8.
15. Edholm D, Molin M, Bajak E, Akusjarvi G. Adenovirus vector designed for expression of toxic proteins. J Virol 2001;75,9579-84.
16. Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, et al. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther 2001;8: 946-53.
17. Zinn KR, Chaudhuri TR, Buchsbaum DJ, Mountz JM, Rogers BE. Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nucl Med Biol 2001;28:135-44.
18. Johnson M, Sato M, Burton J, Gambhir SS, Carey M, Wu L. Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach. Mol Imaging 2005;4:463-72.
19. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001;358:727-9.
20. Cascante A, Abate-Daga D, Garcia-Rodríguez L, González JR, Alemany R, Fillat C. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model. Gene Ther 2007;14:1471-80.